Birdwatch Note
2024-10-17 16:03:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Misleading. Medicaid only covers Ozempic if certain criteria are met, such as if you’re taking it for diabetes instead of solely for weight loss. The drug is only FDA approved to treat type 2 diabetes, not weight loss. https://www.singlecare.com/blog/does-medicaid-cover-ozempic/
Written by 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846608289884524977
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1846945236083241139
- noteId - 1846945236083241139
- participantId -
- noteAuthorParticipantId - 2A6B630D0AEA2ACC36E2189A989B042C8F44788D5C6526EF4EAC8856A79A73D8
- createdAtMillis - 1729181033522
- tweetId - 1846608289884524977
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Misleading. Medicaid only covers Ozempic if certain criteria are met, such as if you’re taking it for diabetes instead of solely for weight loss. The drug is only FDA approved to treat type 2 diabetes, not weight loss. https://www.singlecare.com/blog/does-medicaid-cover-ozempic/
Note Ratings
rated at | rated by | |
2024-10-18 22:00:27 -0500 | Rating Details | |
2024-10-18 03:00:36 -0500 | Rating Details | |
2024-10-17 22:09:44 -0500 | Rating Details | |
2024-10-17 19:27:53 -0500 | Rating Details | |
2024-10-17 19:00:55 -0500 | Rating Details | |
2024-10-17 16:43:58 -0500 | Rating Details | |
2024-10-17 14:17:18 -0500 | Rating Details | |
2024-10-17 11:10:04 -0500 | Rating Details | |
2024-10-18 10:53:17 -0500 | Rating Details | |
2024-10-18 09:20:54 -0500 | Rating Details | |
2024-10-18 02:10:33 -0500 | Rating Details | |
2024-10-17 20:09:58 -0500 | Rating Details | |
2024-10-17 15:46:27 -0500 | Rating Details | |
2024-10-17 12:29:57 -0500 | Rating Details | |
2024-10-17 11:39:15 -0500 | Rating Details | |
2024-10-20 20:57:20 -0500 | Rating Details | |
2024-10-18 17:41:13 -0500 | Rating Details | |
2024-10-18 06:44:28 -0500 | Rating Details | |
2024-10-17 19:22:25 -0500 | Rating Details | |
2024-10-17 18:54:13 -0500 | Rating Details | |
2024-10-17 17:22:04 -0500 | Rating Details | |
2024-10-17 11:44:58 -0500 | Rating Details | |
2024-10-17 11:15:11 -0500 | Rating Details | |
2024-10-20 00:17:09 -0500 | Rating Details | |
2024-10-18 08:53:48 -0500 | Rating Details | |
2024-10-18 08:43:21 -0500 | Rating Details | |
2024-10-18 07:56:46 -0500 | Rating Details | |
2024-10-18 06:21:18 -0500 | Rating Details | |
2024-10-18 04:30:38 -0500 | Rating Details | |
2024-10-17 18:23:14 -0500 | Rating Details | |
2024-10-17 12:13:18 -0500 | Rating Details | |
2024-10-17 11:50:33 -0500 | Rating Details | |
2024-10-17 11:23:06 -0500 | Rating Details | |
2024-10-17 11:15:08 -0500 | Rating Details | |
2024-10-18 15:03:07 -0500 | Rating Details | |
2024-10-17 16:08:56 -0500 | Rating Details | |
2024-10-17 15:10:54 -0500 | Rating Details | |
2024-10-17 11:24:33 -0500 | Rating Details |